Research desks at Zee Business backed 5 stocks for short-term gains over the coming weeks, reflecting a broadly bullish market view.
Zee Business issued 15 equity short term recommendations today, targeting gains over a 2 to 4 week horizon. The batch carries a bullish bias — 15 buys against 0 sells — covering 5 stocks.
SBIN attracted 4 separate recommendations from registered analysts — Zee Business issued a buy at ₹1,030.1 targeting ₹12,000; Zee Business issued a buy at ₹725 targeting ₹730; Zee Business issued a buy at ₹1,030.1 targeting ₹3,090; Zee Business issued a buy at ₹1,030 targeting ₹1,130 (stop ₹1,000).
POLICYBZR attracted 4 separate recommendations from registered analysts — Zee Business issued a buy at ₹1,610.8 targeting ₹1,675 (stop ₹1,588); Zee Business issued a buy at ₹1,610.8 targeting ₹11,675 (stop ₹1,150); Zee Business issued a buy at ₹1,610.8 targeting ₹1,675; Zee Business issued a buy at ₹1,610 targeting ₹1,675 (stop ₹1,588).
ULTRACEMCO attracted 2 separate recommendations from registered analysts — Zee Business issued a buy at ₹11,812 targeting ₹12,300; Zee Business issued a buy at ₹11,812 targeting ₹12,300 (stop ₹11,600).
Also covered: VOLTAS (₹1,377.4 → ₹1,520) via Zee Business; AUBANK (₹1,040.6 → ₹512) via Zee Business.
Short-term calls are designed to play out over two to four weeks. Quarterly results, FII flows, and sector rotation remain key variables during the holding period.
All recommendations reproduced here originate exclusively from SEBI-registered Research Analysts and are published for informational purposes only. These are not buy or sell recommendations from this publication. Registration with SEBI does not guarantee returns. Investing in securities markets is subject to market risks — read all related documents carefully before investing.
Disclaimer
All recommendations published on Bharatstox are sourced exclusively from SEBI-registered Research Analysts. Registration with SEBI does not guarantee returns or the performance of the intermediary. Investing in securities markets is subject to market risks. Read all related documents carefully before investing. This article is for informational purposes only and does not constitute investment advice.